CD71 expression in Rosai-Dorfman disease: a useful adjunct marker in the differential diagnosis of histiocytic proliferations. | Synapse
March 1, 2026
CD71 expression in Rosai-Dorfman disease: a useful adjunct marker in the differential diagnosis of histiocytic proliferations.
Key Points
The research investigates the role of CD71 in identifying and differentiating Rosai-Dorfman disease from other histiocytic disorders.
Utilized immunohistochemistry to assess CD71 expression in tissue samples.
Analyzed CD71 as a marker in histiocyte identification.
Compared CD71 expression between Rosai-Dorfman disease and other histiocytic proliferations.
CD71 was shown to be a sensitive marker for histiocytes in Rosai-Dorfman disease.
It effectively helped distinguish RDD from other types of histiocytic proliferations.
Abstract
CD71 immunohistochemistry is a sensitive marker for identifying histiocytes in RDD and serves as a useful adjunct in distinguishing RDD from other histiocytic proliferations.